Global Nephroblastoma Treatment Market: Restraint
The major factor that hinders growth of the global nephroblastoma treatment market includes high treatment cost of nephroblastoma. For instance, according to an article published by the American Society of Clinical Oncology, in November 2018, the cost for a full course of treatment and follow-up was determined to be between US$ 1,490 and US$ 2,093 for a patient with nephroblastoma according to the study at the Butaro Cancer Center of Excellence (BCCOE), located at the Butaro District Hospital in rural northern Rwanda, Central Africa.
Nephroblastoma Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients